Short Interest in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Decreases By 48.0%

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the target of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totaling 11,453 shares, a decrease of 48.0% from the July 15th total of 22,041 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average daily volume of 4,707 shares, the days-to-cover ratio is currently 2.4 days.

Institutional Inflows and Outflows

A hedge fund recently raised its position in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC boosted its position in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 49,739 shares of the company’s stock after purchasing an additional 3,831 shares during the quarter. Hunter Associates Investment Management LLC owned 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 as of its most recent SEC filing.

F/m Emerald Life Sciences Innovation ETF Trading Up 0.6%

NASDAQ:LFSC traded up $0.27 during mid-day trading on Friday, hitting $47.09. The company had a trading volume of 2,228 shares, compared to its average volume of 4,720. F/m Emerald Life Sciences Innovation ETF has a fifty-two week low of $26.75 and a fifty-two week high of $47.68. The business’s fifty day moving average is $44.58 and its two-hundred day moving average is $39.27.

F/m Emerald Life Sciences Innovation ETF Company Profile

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.